521 related articles for article (PubMed ID: 29533866)
1. Aflatoxin B
Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ
Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866
[TBL] [Abstract][Full Text] [Related]
2. Aflatoxin B
Chu YJ; Yang HI; Wu HC; Liu J; Wang LY; Lu SN; Lee MH; Jen CL; You SL; Santella RM; Chen CJ
Int J Cancer; 2017 Aug; 141(4):711-720. PubMed ID: 28509392
[TBL] [Abstract][Full Text] [Related]
3. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
5. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan.
Wang LY; You SL; Lu SN; Ho HC; Wu MH; Sun CA; Yang HI; Chien-Jen C
Cancer Causes Control; 2003 Apr; 14(3):241-50. PubMed ID: 12814203
[TBL] [Abstract][Full Text] [Related]
6. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):846-53. PubMed ID: 19273485
[TBL] [Abstract][Full Text] [Related]
7. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
[TBL] [Abstract][Full Text] [Related]
8. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
10. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
[TBL] [Abstract][Full Text] [Related]
12. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
13. Role of aflatoxin B1 as a risk for primary liver cancer in north Indian population.
Asim M; Sarma MP; Thayumanavan L; Kar P
Clin Biochem; 2011 Oct; 44(14-15):1235-40. PubMed ID: 21854762
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
[TBL] [Abstract][Full Text] [Related]
15. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma.
Chen CJ; Wang LY; Lu SN; Wu MH; You SL; Zhang YJ; Wang LW; Santella RM
Hepatology; 1996 Jul; 24(1):38-42. PubMed ID: 8707279
[TBL] [Abstract][Full Text] [Related]
16. Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.
Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Tsuge M; Chayama K
Hepatology; 2011 Apr; 53(4):1237-45. PubMed ID: 21480328
[TBL] [Abstract][Full Text] [Related]
17. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1.
Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM
Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595
[TBL] [Abstract][Full Text] [Related]
18. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
[TBL] [Abstract][Full Text] [Related]
19. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
[TBL] [Abstract][Full Text] [Related]
20. Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.
Xiang X; Qin HG; You XM; Wang YY; Qi LN; Ma L; Xiang BD; Zhong JH; Li LQ
Cancer Med; 2017 Oct; 6(10):2357-2369. PubMed ID: 28941211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
